Healthcare Triangle Inc. has announced a regulatory issue concerning its continued listing on the Nasdaq Stock Market. The company received notices from Nasdaq indicating non-compliance with several listing rules. Initially, the company failed to meet the Minimum Bid Price Requirement, with its securities trading below $1 for 30 consecutive days. Further, Nasdaq raised public interest concerns due to substantial shareholder dilution from a private placement. Additionally, the company's securities recorded a closing bid price of $0.10 or less for ten consecutive trading days, triggering the Low Priced Stocks Rule. Healthcare Triangle Inc. has responded to the Nasdaq Hearings Panel and is exploring alternative actions to regain compliance. However, there is no assurance of meeting the necessary listing requirements.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.